Your cart is currently empty!
Thought disorders are a group of mental health conditions that primarily affect a person’s thinking process, impacting how they interpret reality, behave, and communicate. This section will explore some of the common presentations of thought disorders in children and adolescents.
Psychosis
Psychosis is a severe symptom of thought disorders characterized by a disconnect from reality. It can manifest through:
Classification of Thought Disorders
Thought disorders can be categorized based on symptom presentation and duration (Table 9-3).
Table 9-3. Classification of Thought Disorders in Children and Adolescents
Diagnosis | Symptoms | Duration of Symptoms | Treatment |
---|---|---|---|
Brief Psychotic Disorder | Hallucinations, delusions, disorganized behavior, or speech | >1 day but <1 month | Antipsychotics |
Schizophreniform Disorder | Hallucinations, delusions, disorganized behavior or speech | >1 month but <6 months | Antipsychotics |
Schizophrenia | Hallucinations, delusions, disorganized behavior or speech, catatonic symptoms, negative symptoms, marked reduction in level of functioning | >6 months | Antipsychotics |
Schizoaffective Disorder | Hallucinations, delusions, disorganized behavior, or thinking | Must have at least 2 weeks of psychotic symptoms in the absence of mood symptoms | Antipsychotics and mood stabilizers (bipolar type) or antidepressants (depressed type) |
Schizophrenia
Schizophrenia is a chronic and severe thought disorder affecting approximately 1% of the population. It typically presents in late adolescence or early adulthood, with a higher prevalence in males during late teens and females in their mid-twenties. People with schizophrenia have an increased risk of mortality due to accidents, natural causes, and substance abuse.
Epidemiology:
Etiology:
The exact cause of schizophrenia is unknown, but several contributing factors are likely involved:
Table 9-4. Biochemical Theories of Schizophrenia
Neurotransmitter | Change | Effects |
---|---|---|
Dopamine | Increase | Positive symptoms (hallucinations, delusions) |
Serotonin | Increase/Decrease | Both positive and negative symptoms |
Glutamate | Increase | PCP (glutamate antagonist) can induce schizophrenia-like symptoms |
Nicotine | Decrease | May improve some cognitive impairments |
GABA | Decrease | May contribute to positive symptoms |
Neuropathology:
Studies suggest structural and functional abnormalities in specific brain regions in schizophrenia (Table 9-5).
Table 9-5. Schizophrenia-Associated Neuropathology
Brain Area | Change |
---|---|
Ventricles | Increased size |
Symmetry | Decreased (asymmetry in some brain structures) |
Limbic System | Decreased activity |
Prefrontal Cortex | Decreased activity |
Thalamus | Decreased activity |
Basal Ganglia and Cerebellum | Increase/decrease in activity |
Additional Points:
Bibliography: